Loading...
Recombinant Peptides as Biomarkers for Tumor Response to Molecular Targeted Therapy
PURPOSE: Phage display technology can be used to identify peptide sequences which bind rapidly and specifically to tumors responding to sunitinib therapy. These peptides may help to address problems with current methods of assessing tumor response to therapy which can be slow and have limited usage....
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
2009
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763341/ https://ncbi.nlm.nih.gov/pubmed/19825959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0945 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|